To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) single-tablet regimen, by considering pre-existent resistance (pRes).
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen
CALCAGNO, Andrea;VENDEMIATI, GIULIA;BONORA, Stefano;DI PERRI, Giovanni;
2016-01-01
Abstract
To evaluate the maintenance of virological suppression (VS) in antiretroviral-treated HIV-1-suppressed patients switching to a tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) single-tablet regimen, by considering pre-existent resistance (pRes).
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
RAMs Rilpi failure Armenia JAC 2016.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
249.58 kB
Formato
Adobe PDF
|
249.58 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
